Medical Care

Global PCR and NGS-Based Molecular Diagnostics Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for PCR and NGS-Based Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCR and NGS-Based Molecular Diagnostics.
The PCR and NGS-Based Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PCR and NGS-Based Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PCR and NGS-Based Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermofisher
Illumine
Paragon Genomics
Roche
Qiagen
Bioo Scientific
Agilent
Pillar Biosciences
LC-Bio Technologies (Hangzhou) CO. LTD.
iGen Technologies
Burning Rock
Segment by Type
Biomarker Discovery
Blood Sample Testig
Others
Segment by Application
Hospitals
Academics/Research Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PCR and NGS-Based Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biomarker Discovery
1.2.3 Blood Sample Testig
1.2.4 Others
1.3 Market by Application
1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Academics/Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global PCR and NGS-Based Molecular Diagnostics Growth Trends by Region
2.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 PCR and NGS-Based Molecular Diagnostics Market Dynamics
2.3.1 PCR and NGS-Based Molecular Diagnostics Industry Trends
2.3.2 PCR and NGS-Based Molecular Diagnostics Market Drivers
2.3.3 PCR and NGS-Based Molecular Diagnostics Market Challenges
2.3.4 PCR and NGS-Based Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue
3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of PCR and NGS-Based Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of PCR and NGS-Based Molecular Diagnostics, Product and Application
3.7 Global Key Players of PCR and NGS-Based Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2020-2031)
6.2 North America PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2020-2031)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermofisher
11.1.1 Thermofisher Company Details
11.1.2 Thermofisher Business Overview
11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.1.5 Thermofisher Recent Development
11.2 Illumine
11.2.1 Illumine Company Details
11.2.2 Illumine Business Overview
11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.2.5 Illumine Recent Development
11.3 Paragon Genomics
11.3.1 Paragon Genomics Company Details
11.3.2 Paragon Genomics Business Overview
11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.3.5 Paragon Genomics Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.5.5 Qiagen Recent Development
11.6 Bioo Scientific
11.6.1 Bioo Scientific Company Details
11.6.2 Bioo Scientific Business Overview
11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.6.5 Bioo Scientific Recent Development
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.7.5 Agilent Recent Development
11.8 Pillar Biosciences
11.8.1 Pillar Biosciences Company Details
11.8.2 Pillar Biosciences Business Overview
11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.8.5 Pillar Biosciences Recent Development
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
11.10 iGen Technologies
11.10.1 iGen Technologies Company Details
11.10.2 iGen Technologies Business Overview
11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.10.5 iGen Technologies Recent Development
11.11 Burning Rock
11.11.1 Burning Rock Company Details
11.11.2 Burning Rock Business Overview
11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
11.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
11.11.5 Burning Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biomarker Discovery
Table 3. Key Players of Blood Sample Testig
Table 4. Key Players of Others
Table 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2020-2025)
Table 9. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2026-2031)
Table 11. PCR and NGS-Based Molecular Diagnostics Market Trends
Table 12. PCR and NGS-Based Molecular Diagnostics Market Drivers
Table 13. PCR and NGS-Based Molecular Diagnostics Market Challenges
Table 14. PCR and NGS-Based Molecular Diagnostics Market Restraints
Table 15. Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players (2020-2025)
Table 17. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2024)
Table 18. Ranking of Global Top PCR and NGS-Based Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of PCR and NGS-Based Molecular Diagnostics, Headquarters and Area Served
Table 21. Global Key Players of PCR and NGS-Based Molecular Diagnostics, Product and Application
Table 22. Global Key Players of PCR and NGS-Based Molecular Diagnostics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 26. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 28. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 30. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 32. North America PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermofisher Company Details
Table 48. Thermofisher Business Overview
Table 49. Thermofisher PCR and NGS-Based Molecular Diagnostics Product
Table 50. Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 51. Thermofisher Recent Development
Table 52. Illumine Company Details
Table 53. Illumine Business Overview
Table 54. Illumine PCR and NGS-Based Molecular Diagnostics Product
Table 55. Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 56. Illumine Recent Development
Table 57. Paragon Genomics Company Details
Table 58. Paragon Genomics Business Overview
Table 59. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product
Table 60. Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 61. Paragon Genomics Recent Development
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche PCR and NGS-Based Molecular Diagnostics Product
Table 65. Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Qiagen Company Details
Table 68. Qiagen Business Overview
Table 69. Qiagen PCR and NGS-Based Molecular Diagnostics Product
Table 70. Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 71. Qiagen Recent Development
Table 72. Bioo Scientific Company Details
Table 73. Bioo Scientific Business Overview
Table 74. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product
Table 75. Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 76. Bioo Scientific Recent Development
Table 77. Agilent Company Details
Table 78. Agilent Business Overview
Table 79. Agilent PCR and NGS-Based Molecular Diagnostics Product
Table 80. Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 81. Agilent Recent Development
Table 82. Pillar Biosciences Company Details
Table 83. Pillar Biosciences Business Overview
Table 84. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product
Table 85. Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 86. Pillar Biosciences Recent Development
Table 87. LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
Table 88. LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
Table 89. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product
Table 90. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 91. LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
Table 92. iGen Technologies Company Details
Table 93. iGen Technologies Business Overview
Table 94. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product
Table 95. iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 96. iGen Technologies Recent Development
Table 97. Burning Rock Company Details
Table 98. Burning Rock Business Overview
Table 99. Burning Rock PCR and NGS-Based Molecular Diagnostics Product
Table 100. Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 101. Burning Rock Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report


List of Figures
Figure 1. PCR and NGS-Based Molecular Diagnostics Picture
Figure 2. Global PCR and NGS-Based Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PCR and NGS-Based Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Biomarker Discovery Features
Figure 5. Blood Sample Testig Features
Figure 6. Others Features
Figure 7. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Academics/Research Institutions Case Studies
Figure 11. Others Case Studies
Figure 12. PCR and NGS-Based Molecular Diagnostics Report Years Considered
Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global PCR and NGS-Based Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 16. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players in 2024
Figure 17. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue in 2024
Figure 19. North America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2020-2031)
Figure 21. United States PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Country (2020-2031)
Figure 25. Germany PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Share by Region (2020-2031)
Figure 33. China PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2020-2031)
Figure 41. Mexico PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Share by Country (2020-2031)
Figure 45. Turkey PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Thermofisher Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 49. Illumine Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 50. Paragon Genomics Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 52. Qiagen Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 53. Bioo Scientific Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 54. Agilent Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 55. Pillar Biosciences Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 56. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 57. iGen Technologies Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 58. Burning Rock Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies